Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 8,318,400 | 3,232,000 | -204,100 | 2,737,600 | 2,408,400 |
| Depreciation Amortization | 1,232,600 | 1,609,000 | 1,567,300 | 1,496,600 | 1,427,700 |
| Income taxes - deferred | 62,400 | 326,800 | -787,900 | 439,500 | -748,400 |
| Accounts receivable | -127,200 | -996,700 | -357,000 | -709,400 | -304,500 |
| Accounts payable and accrued liabilities | -477,700 | -284,500 | 916,300 | 1,123,800 | 207,900 |
| Other Working Capital | -1,687,200 | -2,378,700 | 3,204,900 | -484,100 | -1,139,200 |
| Other Operating Activity | -2,484,700 | 4,016,600 | 1,276,100 | 247,000 | 1,112,700 |
| Operating Cash Flow | $4,836,600 | $5,524,500 | $5,615,600 | $4,851,000 | $2,964,600 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 93,900 | 2,440,300 | 1,462,800 | 314,600 | 1,319,600 |
| PPE Investments | -1,033,900 | -1,210,600 | -1,076,800 | -963,600 | -973,600 |
| Net Acquisitions | -6,562,900 | N/A | -882,100 | -45,000 | -5,283,100 |
| Purchase Of Investment | -247,500 | -837,900 | -4,611,600 | -4,346,000 | -3,226,500 |
| Sale Of Investment | 609,800 | 3,509,500 | 2,586,000 | 2,086,000 | 3,068,400 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | 410,000 |
| Other Investing Activity | -942,300 | -1,995,300 | -1,261,900 | -185,100 | 5,122,000 |
| Investing Cash Flow | $-8,082,900 | $1,906,000 | $-3,783,600 | $-3,139,100 | $26,800 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 995,400 | -2,197,900 | 1,397,500 | 1,293,200 | -2,680,600 |
| Debt Issued | 6,556,400 | 2,477,700 | 2,232,000 | 1,206,600 | 4,454,700 |
| Debt Repayment | -2,866,400 | -1,009,100 | -630,600 | -200 | -1,955,700 |
| Common Stock Issued | N/A | 1,659,700 | N/A | N/A | N/A |
| Common Stock Repurchased | -4,400,000 | -4,150,700 | -299,800 | -600,100 | -749,500 |
| Dividend Paid | -2,409,800 | -2,311,800 | -2,192,100 | -2,158,500 | -2,127,300 |
| Other Financing Activity | -200,100 | -372,800 | -364,400 | -300,800 | -52,600 |
| Financing Cash Flow | $-2,324,500 | $-5,904,900 | $142,600 | $-559,800 | $-3,111,000 |
| Exchange Rate Effect | -89,900 | -63,600 | -20,500 | -236,400 | -85,600 |
| Beginning Cash Position | 7,998,200 | 6,536,200 | 4,582,100 | 3,666,400 | 3,871,600 |
| End Cash Position | 2,337,500 | 7,998,200 | 6,536,200 | 4,582,100 | 3,666,400 |
| Net Cash Flow | $-5,660,700 | $1,462,000 | $1,954,100 | $915,700 | $-205,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,836,600 | 5,524,500 | 5,615,600 | 4,851,000 | 2,964,600 |
| Capital Expenditure | -1,033,900 | -1,210,600 | -1,076,800 | -1,037,000 | -1,066,200 |
| Free Cash Flow | 3,802,700 | 4,313,900 | 4,538,800 | 3,814,000 | 1,898,400 |